Clinical and echocardiographic findings of the study population
Variable | Data |
---|---|
Clinical findings | |
Age (years) | 68 ± 10 |
Male sex | 341 (64%) |
BMI (kg/m2) | 26.8 ± 4.3 |
BMI ≥ 30 | 104 (20%) |
Diabetes mellitus | 142 (27%) |
Arterial hypertension | 344 (65%) |
Hypercholesterolemia | 324 (61%) |
Current smoker | 112 (21%) |
Left bundle branch block | 26 (5%) |
Permanent atrial fibrillation | 21 (4%) |
Paced rhythm | 15 (3%) |
Prior myocardial infarction | 98 (18%) |
Prior CABG | 15 (3%) |
Prior PCI | 125 (24%) |
Known CAD | 150 (28%) |
Ongoing medical therapy | |
Angiotensin-converting-enzyme inhibitors | 151 (28%) |
Angiotensin receptor blocker | 105 (20%) |
Calcium-antagonist | 123 (23%) |
β-Blocker | 189 (36%) |
Statin | 309 (58%) |
Antiplatelet | 229 (43%) |
Anticoagulant | 31 (6%) |
Echocardiographic findings | |
Heart rate (beats/min) | 68 ± 11 |
SBP (mmHg) | 134 ± 16 |
DBP (mmHg) | 79 ± 9 |
LVEDV (mL) | 88 ± 28 |
LVESV (mL) | 37 ± 19 |
SBP/LVESV | 4.4 ± 1.8 |
LVEF | 59 ± 9 |
LVEF < 50% | 58 (11%) |
B-lines | 1.4 ± 3.8 |
B-lines ≥ 2 | 108 (20%) |
GLS (%) | 16.3 ± 3.2 |
GLS ≤ 16.2% | 223 (42%) |
The data presented are mean ± SD or number (%) of patients. BMI: body mass index; CABG: coronary artery bypass grafting; PCI: percutaneous coronary intervention; CAD: coronary artery disease; SBP: systolic blood pressure; DBP: diastolic blood pressure; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; LVEF: left ventricular ejection fraction
LC: Conceptualization, Data curation, Formal Analysis, Writing—original draft. MFO, MF and FB: Data curation, Formal Analysis, Writing—review & editing. All authors approved the submitted version of the manuscript.
The authors declare that they have no conflicts of interest.
The study complies with the Declaration of Helsinki and was approved by the institutional ethics committee (Azienda USL Toscana Nordovest, decreto N. 1954, June 19, 2018).
The informed consent to participate in the study was obtained from all participants.
The informed consent to publication was obtained from relevant participants.
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Not applicable.
© The Author(s) 2023.